These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 9384405)

  • 1. Effects of ifenprodil, a polyamine site NMDA receptor antagonist, on reperfusion injury after transient focal cerebral ischemia.
    Doğan A; Rao AM; Başkaya MK; Rao VL; Rastl J; Donaldson D; Dempsey RJ
    J Neurosurg; 1997 Dec; 87(6):921-6. PubMed ID: 9384405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of brain edema, blood-brain barrier breakdown, and injury volume by ifenprodil, a polyamine-site N-methyl-D-aspartate receptor antagonist, after experimental traumatic brain injury in rats.
    Dempsey RJ; Başkaya MK; Doğan A
    Neurosurgery; 2000 Aug; 47(2):399-404; discussion 404-6. PubMed ID: 10942013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of ifenprodil on ischemic injury size, blood-brain barrier breakdown, and edema formation in focal cerebral ischemia.
    Başkaya MK; Rao AM; Donaldson D; Prasad MR; Dempsey RJ
    Neurosurgery; 1997 Feb; 40(2):364-70; discussion 370-1. PubMed ID: 9007871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextrorphan reduces infarct volume, vascular injury, and brain edema after ischemic brain injury.
    Du C; Hu R; Hsu CY; Choi DW
    J Neurotrauma; 1996 Apr; 13(4):215-22. PubMed ID: 8860202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
    Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
    J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.
    Tatlisumak T; Takano K; Meiler MR; Fisher M
    Stroke; 1998 Jan; 29(1):190-5. PubMed ID: 9445350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of endothelin type A receptor antagonist on brain edema and injury after transient middle cerebral artery occlusion in rats.
    Matsuo Y; Mihara Si ; Ninomiya M; Fujimoto M
    Stroke; 2001 Sep; 32(9):2143-8. PubMed ID: 11546909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection by the stable nitroxide Tempol during reperfusion in a rat model of transient focal ischemia.
    Rak R; Chao DL; Pluta RM; Mitchell JB; Oldfield EH; Watson JC
    J Neurosurg; 2000 Apr; 92(4):646-51. PubMed ID: 10761655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effect of NMDA receptor glycine recognition site antagonism persists when brain temperature is controlled.
    Takaoka S; Bart RD; Pearlstein R; Brinkhous A; Warner DS
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):161-7. PubMed ID: 9040495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of vasogenic edema and infarction by MK-801 in rats after temporary focal cerebral ischemia.
    Yang G; Chan PH; Chen SF; Babuna OA; Simon RP; Weinstein PR
    Neurosurgery; 1994 Feb; 34(2):339-45; discussion 345. PubMed ID: 8177396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of memantine against ischemia-reperfusion injury in spontaneously hypertensive rats.
    Dogan A; Eras MA; Rao VL; Dempsey RJ
    Acta Neurochir (Wien); 1999; 141(10):1107-13. PubMed ID: 10550658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-artery infusion of recombinant human erythropoietin reduces blood-brain barrier disruption in rats following cerebral ischemia and reperfusion.
    Wang R; Wu X; Liang J; Qi Z; Liu X; Min L; Ji X; Luo Y; Zhao H
    Int J Neurosci; 2015; 125(9):693-702. PubMed ID: 25226558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective efficacy and therapeutic window of the high-affinity N-methyl-D-aspartate antagonist conantokin-G: in vitro (primary cerebellar neurons) and in vivo (rat model of transient focal brain ischemia) studies.
    Williams AJ; Dave JR; Phillips JB; Lin Y; McCabe RT; Tortella FC
    J Pharmacol Exp Ther; 2000 Jul; 294(1):378-86. PubMed ID: 10871336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.
    Gotti B; Duverger D; Bertin J; Carter C; Dupont R; Frost J; Gaudilliere B; MacKenzie ET; Rousseau J; Scatton B
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1211-21. PubMed ID: 2849668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of focal cerebral ischemia with synthetic oligopeptide corresponding to lectin domain of selectin.
    Morikawa E; Zhang SM; Seko Y; Toyoda T; Kirino T
    Stroke; 1996 May; 27(5):951-5; discussion 956. PubMed ID: 8623118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothermic protection in rat focal ischemia models: strain differences and relevance to "reperfusion injury".
    Ren Y; Hashimoto M; Pulsinelli WA; Nowak TS
    J Cereb Blood Flow Metab; 2004 Jan; 24(1):42-53. PubMed ID: 14688615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effect of agmatine in rats with transient cerebral ischemia using MR imaging and histopathologic evaluation.
    Huang YC; Tzeng WS; Wang CC; Cheng BC; Chang YK; Chen HH; Lin PC; Huang TY; Chuang TJ; Lin JW; Chang CP
    Magn Reson Imaging; 2013 Sep; 31(7):1174-81. PubMed ID: 23642800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of postischemic administration of progesterone in spontaneously hypertensive rats with focal cerebral ischemia.
    Kumon Y; Kim SC; Tompkins P; Stevens A; Sakaki S; Loftus CM
    J Neurosurg; 2000 May; 92(5):848-52. PubMed ID: 10794300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia.
    Vakili A; Hosseinzadeh F; Sadogh T
    Brain Res; 2007 Sep; 1170():97-102. PubMed ID: 17698046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mGluR1 antagonist decreases tyrosine phosphorylation of NMDA receptor and attenuates infarct size after transient focal cerebral ischemia.
    Murotomi K; Takagi N; Takayanagi G; Ono M; Takeo S; Tanonaka K
    J Neurochem; 2008 Jun; 105(5):1625-34. PubMed ID: 18248625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.